Vanguard Recombishield Injectable
فانجارد ريكومبيشيلد لقاح البورديتيلا بالحقن
Vanguard Recombishield is a cellular recombinant subunit vaccine for the vaccination of healthy dogs 8 weeks of age or older as an aid in preventing canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica. Highly purified subunit formulation minimizes localized post-vaccinal injection site discomfort.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
25 x 1-dose and 50 x 1-dose prefilled single-dose vials with sterile diluent
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 1 mL subcutaneous injection | Subcutaneous (SC) | Primary 2 doses 3-4 weeks apart; annual revaccination |
Withdrawal Periods
No withdrawal information available.
Indications
-
Aid in the prevention of canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica in healthy dogs 8 weeks of age or older.
Contraindications
-
Do not vaccinate diseased, febrile, or immunocompromised dogs.
Precautions
-
Contains gentamicin and thimerosal as preservatives.
-
In case of anaphylaxis, administer epinephrine immediately.
Side Effects
-
Minimal transient swelling or slight tenderness at injection site; lethargy resolving within 24 hours.
Images
Documents
-
Download
Vanguard Recombishield Injectable Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.